TY - JOUR
T1 - Establishing the cut-off scores for the severity ranges of schizophrenia on the BPRS-6 scale
T2 - findings from the REAP-AP
AU - Park, Seon Cheol
AU - Jang, Eun Young
AU - Kim, Kiwon
AU - Lee, Hoseon
AU - Choi, Joonho
AU - Dan, Amitava
AU - Hussain, Arshad
AU - Tanra, Andi Jayalangkara
AU - Kato, Takahiro A.
AU - Chee, Kok Yoon
AU - Lin, Sih Ku
AU - Tan, Chay Hoon
AU - Javed, Afzal
AU - Sartorius, Norman
AU - Shinfuku, Naotaka
AU - Park, Yong Chon
N1 - Publisher Copyright:
© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2019/10/2
Y1 - 2019/10/2
N2 - Objective: Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP), our study aimed to establish the remission and severity ranges (mild, moderate, and severe) of schizophrenia on the Brief Psychiatric Rating Scale-6 (BPRS-6). Methods: A total of 1,438 patients with schizophrenia from India, Indonesia, Japan, Malaysia, and Taiwan were enrolled in the study. Using the receiver operating characteristic (ROC) curve analyses, the optimal cut-off scores for the remission and severity ranges on the BPRS-6 were established. Results: The scalability of the BPRS-6 was considered to have an acceptable “unidimensionality” (coefficient of scalability = 0.43). The cut-off scores for the remission of schizophrenia and mild, moderate, and severe schizophrenia can be optimally defined as the BPRS-6 total score of <5, 5–9, 10–19 and >20, respectively. Conclusion: The BPRS-6 can be a promising, brief, and unidimensional rating scale to supplement the measurement-based care of schizophrenia.
AB - Objective: Using data from the Research on Asian Psychotropic Prescription Patterns for Antipsychotics (REAP-AP), our study aimed to establish the remission and severity ranges (mild, moderate, and severe) of schizophrenia on the Brief Psychiatric Rating Scale-6 (BPRS-6). Methods: A total of 1,438 patients with schizophrenia from India, Indonesia, Japan, Malaysia, and Taiwan were enrolled in the study. Using the receiver operating characteristic (ROC) curve analyses, the optimal cut-off scores for the remission and severity ranges on the BPRS-6 were established. Results: The scalability of the BPRS-6 was considered to have an acceptable “unidimensionality” (coefficient of scalability = 0.43). The cut-off scores for the remission of schizophrenia and mild, moderate, and severe schizophrenia can be optimally defined as the BPRS-6 total score of <5, 5–9, 10–19 and >20, respectively. Conclusion: The BPRS-6 can be a promising, brief, and unidimensional rating scale to supplement the measurement-based care of schizophrenia.
UR - http://www.scopus.com/inward/record.url?scp=85076878402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076878402&partnerID=8YFLogxK
U2 - 10.1080/24750573.2019.1695994
DO - 10.1080/24750573.2019.1695994
M3 - Article
AN - SCOPUS:85076878402
VL - 29
SP - 895
EP - 898
JO - Psychiatry and Clinical Psychopharmacology
JF - Psychiatry and Clinical Psychopharmacology
SN - 2475-0573
IS - 4
ER -
